Chew, H. (2021, June 02). Sinovac COVID-19 vaccine to be allowed in Singapore under special access route after WHO approval. Retrieved June 16, 2021, from https://www.channelnewsasia.com/news/singapore/sinovac-covid-19-vaccine-special-access-route-vaccination-moh-14933072
COVID-19 vaccines explained. (2021, April 21). Retrieved June 16, 2021, from https://news.nus.edu.sg/covid-19-vaccines-explained/
Dyer, O. (2021). Covid-19: Chinese vaccines may need changes to Improve efficacy, admits official. BMJ, 373(N969). doi:10.1136/bmj.n969
FAQs - Special Access Route (SAR) vaccines. (2021, June 5). Retrieved June 16, 2021, from https://www.moh.gov.sg/covid-19/vaccination/faqs/faqs---special-access-route-(sar)-vaccines
Goh, T. (2021, June 04). MOH allows special access to Sinovac COVID-19 vaccine through private healthcare sector. Retrieved June 16, 2021, from https://www.straitstimes.com/singapore/health/sinovac-approved-under-special-access-route-moh
Hermesauto. (2021, May 12). China's Sinovac COVID-19 vaccine found highly effective in real world study. Retrieved June 16, 2021, from https://www.straitstimes.com/asia/east-asia/chinas-sinovac-covid-19-vaccine-found-highly-effective-in-real-world-study
Jeong, M. (2021, June 12). Sinovac COVID-19 vaccine: What are the side effects? Retrieved June 16, 2021, from https://www.medicalnewstoday.com/articles/sinovac-covid-19-vaccine-what-are-the-side-effects
Jeong, M. (2021, May 13). Global COVID-19 vaccine summary: Side effects. Retrieved June 16, 2021, from https://www.medicalnewstoday.com/articles/global-covid-19-vaccine-summary-side-effects
Kucukgocmen, A. (2021, March 03). Turkish study revises down Sinovac COVID-19 vaccine efficacy to 83.5% (1410376851 1027540791 D. Evans, Ed.). Retrieved June 16, 2021, from https://www.reuters.com/article/health-coronavirus-turkey-sinovac-int-idUSKBN2AV18P
Nebehay, S., & Kelland, K. (2021, March 31). Sinopharm, Sinovac COVID-19 Vaccine data show efficacy: WHO. Retrieved June 16, 2021, from https://www.reuters.com/article/us-health-coronavirus-who-china-vaccines-idUSKBN2BN1K8
The Sinovac COVID-19 vaccine: What you need to know. (2021, June 2). Retrieved June 16, 2021, from https://www.who.int/news-room/feature-stories/detail/the-sinovac-covid-19-vaccine-what-you-need-to-know
Sinovac: Coronavac. (n.d.). Retrieved June 16, 2021, from https://covid19.trackvaccines.org/vaccines/7/
Understanding mRNA COVID-19 Vaccines. (2021, March 4). Retrieved June 16, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations. (2021, June 1). Retrieved June 16, 2021, from https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations
Wilder-Smith, A., Hombach, J., Marti, M., & O'Brien, K. (2021, May 24). Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac (Rep.). Retrieved June 16, 2021, from World Health Organisation website: https://apps.who.int/iris/bitstream/handle/10665/341454/WHO-2019-nCoV-vaccines-SAGE-recommendation-Sinovac-CoronaVac-2021.1-eng.pdf
World Health Organization (WHO). (2021, June 14). Retrieved June 16, 2021, from https://covid19.trackvaccines.org/agency/who/
Zimlich, R. (2021, May 14). Comparing the AstraZeneca (British) and Sinovac (Chinese) COVID-19 Vaccines. Retrieved June 16, 2021, from https://www.healthline.com/health/astrazeneca-vs-sinovac